Pacira BioSciences Inc (PCRX)
26.80
+0.70
(+2.68%)
USD |
NASDAQ |
Apr 23, 16:00
26.80
0.00 (0.00%)
After-Hours: 17:39
Pacira BioSciences Shareholders Equity (Quarterly): 870.13M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 870.13M |
September 30, 2023 | 831.55M |
June 30, 2023 | 807.98M |
March 31, 2023 | 768.04M |
December 31, 2022 | 775.01M |
September 30, 2022 | 770.12M |
June 30, 2022 | 756.64M |
March 31, 2022 | 709.58M |
December 31, 2021 | 730.41M |
September 30, 2021 | 718.60M |
June 30, 2021 | 687.17M |
March 31, 2021 | 650.82M |
December 31, 2020 | 619.69M |
September 30, 2020 | 584.69M |
June 30, 2020 | 388.15M |
March 31, 2020 | 374.04M |
December 31, 2019 | 354.94M |
September 30, 2019 | 346.16M |
June 30, 2019 | 341.65M |
March 31, 2019 | 327.52M |
December 31, 2018 | 321.23M |
September 30, 2018 | 301.27M |
June 30, 2018 | 290.51M |
March 31, 2018 | 278.52M |
December 31, 2017 | 279.48M |
Date | Value |
---|---|
September 30, 2017 | 264.80M |
June 30, 2017 | 261.05M |
March 31, 2017 | 270.63M |
December 31, 2016 | 218.98M |
September 30, 2016 | 214.15M |
June 30, 2016 | 228.35M |
March 31, 2016 | 226.17M |
December 31, 2015 | 218.39M |
September 30, 2015 | 209.01M |
June 30, 2015 | 195.28M |
March 31, 2015 | 184.02M |
December 31, 2014 | 171.14M |
September 30, 2014 | 155.07M |
June 30, 2014 | 147.97M |
March 31, 2014 | 35.71M |
December 31, 2013 | 41.25M |
September 30, 2013 | 49.12M |
June 30, 2013 | 59.14M |
March 31, 2013 | 69.79M |
December 31, 2012 | 65.86M |
September 30, 2012 | 80.44M |
June 30, 2012 | 94.50M |
March 31, 2012 | 37.24M |
December 31, 2011 | 48.27M |
September 30, 2011 | 13.88M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
341.65M
Minimum
Jun 2019
870.13M
Maximum
Dec 2023
636.07M
Average
709.58M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Dynavax Technologies Corp | 622.07M |
Arbutus Biopharma Corp | 106.02M |
Chimerix Inc | 193.03M |
Karyopharm Therapeutics Inc | -136.21M |
FibroGen Inc | -204.17M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.574B |
Total Liabilities (Quarterly) | 704.26M |
Debt to Equity Ratio | 0.6004 |
Current Ratio | 5.237 |
Net Debt Paydown Yield | 2.87% |